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Background:  Although the pathogenic role of T cells in acute coronary syndromes (ACS) is well established, the complex functional interplay of 
the various T-cell subsets, leading to different cytokine/chemokine production in this disorder is far from clear. Aim. To determine the pattern of 
cytokine/chemokine expression profile within the coronary circulation of patients with ACS and compare it to patients with stable angina (SA). 
Methods and Results:  In 44 patients (ACS, n=28; SA, n=16), blood samples were simultaneously obtained from the aorta (Ao) and the coronary 
sinus (CS) during diagnostic coronary angiography. Cytokine/chemokine expression profile was measured using Luminex™ technology, which allows 
measurement of up to 100 different analytes in the same 50 μl-sample. The following cytokines/chemokines were measured: EGF, Eotaxin, FGF-β, 
G-CSF, GM-CSF, HGF, IFN-α, IL-10, IL-12P40/P70, IL-13, IL-15, IL-1B, IL-1Rα, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, INF-γ, IP-10, MCP-1, MIG, MIP-
1a, MIP-1b, TNF-α, RANTES, VEGF. Intracoronary production of all cytokines/chemokines was calculated as a Δ% of the CS/Ao values. In patients 
with ACS, a significant intracoronary production of IL-1B (19.1±6.5 vs 0.1±5.4, p<.05), Eotaxin (27.1±7.6 vs 3.2±6.9, p<.05), RANTES (4.4±1.1 vs 
-3.1±2.7, p<.05), IL-6 (25.6±10.8 vs 4.0±3.2, p<.05), INF-γ (252±95 vs 28±32, p<.01), IL-1Rα (19.2±5.3 vs 3.1±4.5, p<.05), TNF-α (22.9±6.4 vs 
5.3± 8.1, p<.01), IL-13 (136±47 vs 22±19, p<.01) was observed as compared to patients with SA. All other measured cytokines/chemokines did not 
differ significantly across the coronary circulation in patients with ACS as compared to patients with SA. 
Conclusions:  In patients with ACS, a significant intracoronary production of selected cytokines/chemokines occurs, indicating that this disorder is 
characterized by a network of local inflammatory responses more complex than the well-characterized Th1/Th2 paradigm.
